FIVE OAKS FAMILY PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P84004 | MANCHESTER, M11 3BB
Showing results 51-100 of 544
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Prednisolone | 893 | 34.2K | £1.0K | +11.8% ▲ |
| Promethazine hydrochloride | 888 | 35.1K | £5.0K | +148.5% ▲ |
| Tramadol hydrochloride | 888 | 79.1K | £3.8K | +23.9% ▲ |
| Famotidine | 887 | 28.0K | £17.2K | +81.8% ▲ |
| Codeine phosphate | 851 | 73.8K | £2.5K | +18.4% ▲ |
| Allopurinol | 799 | 34.2K | £739 | -22.5% ▼ |
| Fluoxetine hydrochloride | 791 | 29.3K | £930 | -22.0% ▼ |
| Budesonide | 774 | 1,743 | £26.9K | +42.8% ▲ |
| Indapamide | 771 | 27.3K | £1.1K | -10.6% ▼ |
| 767 | 10.3K | £8.1K | +15.5% ▲ | |
| Glucose blood testing reagents | 765 | 68.7K | £10.0K | -3.1% ▼ |
| Ezetimibe | 719 | 17.7K | £3.1K | +1.1% vs avg |
| Sildenafil (Erectile Dysfunction) | 698 | 5,118 | £723 | +38.5% ▲ |
| Losartan potassium | 659 | 21.3K | £556 | -62.8% ▼ |
| Gliclazide | 651 | 38.5K | £1.0K | -23.5% ▼ |
| Cetirizine hydrochloride | 645 | 48.6K | £2.6K | +29.1% ▲ |
| Rivaroxaban | 632 | 18.0K | £11.9K | +3.3% ▲ |
| Oxycodone hydrochloride | 612 | 69.1K | £6.6K | +139.1% ▲ |
| Docusate sodium | 611 | 45.7K | £3.3K | +64.8% ▲ |
| Quetiapine | 611 | 23.8K | £7.3K | -1.9% vs avg |
| Macrogol 3350 | 609 | 30.4K | £5.3K | -35.1% ▼ |
| 609 | 84.3K | £3.9K | +28.4% ▲ | |
| Fexofenadine hydrochloride | 604 | 26.0K | £1.2K | -29.0% ▼ |
| 590 | 621 | £27.6K | +89.9% ▲ | |
| Canagliflozin | 584 | 18.6K | £23.1K | +306.7% ▲ |
| Bendroflumethiazide | 577 | 18.8K | £311 | -25.4% ▼ |
| Warfarin sodium | 570 | 27.9K | £926 | +20.9% ▲ |
| Ferrous sulfate | 566 | 19.5K | £652 | +10.1% ▲ |
| Levetiracetam | 510 | 54.9K | £2.6K | +11.4% ▲ |
| Hydrocortisone | 498 | 14.5K | £2.2K | +11.1% ▲ |
| Fluticasone/umeclidinium/vilanterol | 494 | 527 | £22.3K | +110.7% ▲ |
| Rosuvastatin calcium | 491 | 16.9K | £531 | -45.3% ▼ |
| 488 | 1,021 | £35.6K | -10.5% ▼ | |
| Fluticasone propionate (Inhalation) | 486 | 556 | £13.5K | +25.6% ▲ |
| Alendronic acid | 482 | 2,076 | £469 | -35.7% ▼ |
| Latanoprost | 469 | 8,548 | £2.9K | -3.4% ▼ |
| Doxycycline hyclate | 465 | 4,993 | £492 | -9.3% ▼ |
| Isosorbide mononitrate | 459 | 17.4K | £2.7K | -30.6% ▼ |
| Alogliptin | 457 | 15.6K | £14.1K | +80.2% ▲ |
| Mebeverine hydrochloride | 451 | 39.2K | £3.7K | +45.2% ▲ |
| Lactulose | 437 | 291.1K | £2.7K | +32.7% ▲ |
| Insulin aspart | 437 | 1,929 | £14.1K | +14.8% ▲ |
| 430 | 4,626 | £2.1K | +72.3% ▲ | |
| Tiotropium bromide | 424 | 5,776 | £11.1K | +39.5% ▲ |
| Insulin glargine | 423 | 1,428 | £13.3K | +49.0% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 419 | 453 | £6.4K | +269.4% ▲ |
| Irbesartan | 413 | 16.6K | £890 | +69.5% ▲ |
| Ibuprofen | 413 | 39.4K | £1.6K | -18.8% ▼ |
| Sodium valproate | 404 | 38.6K | £5.9K | +27.0% ▲ |
| Olanzapine | 402 | 13.0K | £4.7K | +8.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.